Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.94 SEK | +4.31% | +7.40% | +21.91% |
04-18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
04-18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.91% | 178M | |
+18.09% | 47.02B | |
+48.77% | 41.86B | |
+0.76% | 41.76B | |
-4.27% | 28.8B | |
+12.00% | 26.05B | |
-21.49% | 19.15B | |
+4.35% | 12.55B | |
+28.46% | 12.34B | |
-4.45% | 11.82B |
- Stock Market
- Equities
- HNSA Stock
- News Hansa Biopharma AB
- Hansa Biopharma to Finalize Randomization in Late-stage Kidney Study by Mid-2024